Cannovex BV (NL) Files for License Application to the Dutch OMC
March 25, 2019
Cannovex BV (NL) files the application for an R&D license with the Ducht Office for Medicinal Cannabis (OMC). The license application is for breeding and preservation of cannabis plant varieties for the use in a pharmaceutical production process.
Rendocan is renamed CANNOVEX®
March 18, 2019
Rendocan bvba has been renamed “Cannovex®” and launches new website.
Partnership with Brightlands Campus Greenport Venlo
March 4, 2019
Cannovex BV (NL) signs a partnership with Brightlands Campus Greenport in Venlo and puts op office and pilot research plant at the “Innovatoren”.
Company Receives Building Permit (BE)
March 1, 2019
Rendocan bvba formally receives the building permit to establish a 6.200 m² research and development facility at Agropolis-Kinrooi.
Cannovex BV (The Netherlands) is founded
February 26, 2019
Rendocan bvba founders establish Cannovex BV (The Netherlands).
Regulatory Framework in Belgium Advances
February 26, 2019
Belgian Parliamentary Committee on Public Health gives green light for the establishment of a National Cannabis Agency which is able to license cannabis cultivation for medical and scientific purposes.
Endorsement of University of Maastricht and Province of Limburg (NL)
January 28, 2019
The company receives official endorsement of its plans to research and develop Cannabis-Based Medicine in the Netherlands’ province of Limburg.
Company Files Building Permit
October 1, 2018
Rendocan bvba files for a building permit for its 6.200 m² research facility at Agropolis-Kinrooi.
Facility Lay-out and Design Finished
September 10, 2018
Rendocan bvba has finished its design and the lay-out of the 6.200 m² research facility together with the architects from UAU-Collectiv.
Meeting with Health Canada
December 15, 2017
Rendocan bvba visits Canada and has talks with Health Canada and visits several licensed producers.
Partnership with VITO
September 4, 2017
Rendocan bvba signs a letter of intent for a partnership with the Flemish Institute for Technology and Development (VITO).
Company HQ in Bioville
April 3, 2017
Rendocan bvba establishes its headquarters at the bio-science incubator “Bioville” at the University Campus in Diepenbeek (Belgium).
Partnership with UHasselt
November 1, 2016
Rendocan bvba signs a letter of intent with the University of Hasselt to conduct scientific research on cannabis for medical purposes.
First Meeting FAMHP
October 10, 2016
Rendocan bvba has its first meeting with the Federal Agency on Medicine and Health Products (FAMHP) on their Scientific, Technical and Regulatory Advice application. (STA-3A)
Rendocan bvba Aquires Genetics Database
August 12, 2016
Rendocan bvba acquires a unique, proprietary seed collection of wild-type and landrace cannabis genetics.
Partnership with Agropolis-Kinrooi Business Park
June 10, 2016
Rendocan bvba signs strategic partnership with Agropolis-Kinrooi Business Park and requires exclusive rights on the cultivation of cannabis plants.
June 3, 2016
Company founded under the name “Rendocan bvba” by Joris Vanvinckenroye and Steven Peters.